SEARCH RESULT

Total Matching Records found : 121

What hit this land of plenty?-Sai Manish

75% of the youth. Every third student. 65% of all families in Punjab are in the throes of a sweeping drug addiction. With little or no hope in sight. THE RAILWAY barrier in Angarh, a locality in the border city of Amritsar in Punjab signals the end of too many things. The rule of law. The reign of sense. The fear of crime. The signs of normality. Even the divisions of...

More »

India's patent ruling on cancer may open door for cheaper HIV drugs

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

More »

Govt uses special powers to slash cancer drug price by 97%-Rupali Mukherjee

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...

More »

India's global pharmacy role threatened by EU pact

-AP   Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations on a free-trade pact.  India's prime minister and top EU officials are hoping their summit Friday in New Delhi helps move beyond disagreements over issues like European labor market limits and Indian duties on cars.  But health industry workers and...

More »

Research on Bhopal gas victims waits, not drug trials on them by Abantika Ghosh

The Indian Council of Medical Research (ICMR) has posted an advertisement inviting, by December 31, research proposals on long-term effects of methyl isocyanate (MIC) gas on Bhopal’s residents. However, while it is yet to conduct this research 27 years after the Bhopal gas tragedy caused by MIC that left hundreds dead, data shows that the “gas patients” have been routinely used for clinical trials for new drugs at the Bhopal Memorial...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close